News & Updates
Filter by Specialty:
Modified Atkins diet may be better than keto for childhood drug-resistant epilepsy
Dietary modifications offer short-term benefits in children with drug-resistant epilepsy, but modified Atkins diet appears more tolerable and more likely to reduce the frequency of seizures than ketogenic diet, as shown in a study.
Modified Atkins diet may be better than keto for childhood drug-resistant epilepsy
05 Feb 2023Long-term alcohol intake ups risk of exfoliation glaucoma, glaucoma suspect status
Consumption of alcoholic beverage in the long term may contribute to an increased risk of exfoliation glaucoma or glaucoma suspect (XFG/XFGS) status, suggests a US study.
Long-term alcohol intake ups risk of exfoliation glaucoma, glaucoma suspect status
05 Feb 2023Elevated blood pressure ups retinal vascular occlusion risk
Individuals with high blood pressure (BP), stage 1 hypertension, and stage 2 hypertension are at greater risk of retinal vascular occlusion relative to those with normal BP, as reported in a study.
Elevated blood pressure ups retinal vascular occlusion risk
05 Feb 2023Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
Treatment with dupilumab helps improve the signs and symptoms of erythrodermic atopic dermatitis, with the improvements occurring as early as the first week and being sustained over time, according to a study. The drug has an acceptable safety profile.
Dupilumab yields rapid, lasting improvement in erythrodermic atopic dermatitis
04 Feb 2023Hormone therapies up ILD events in men with prostate cancer
Hormone therapy drugs, such as bicalutamide, flutamide, nilutamide, goserelin, degarelix, and apalutamide, appear to increase the likelihood of developing interstitial lung disease (ILD) events in patients with prostate cancer, reports a study.
Hormone therapies up ILD events in men with prostate cancer
04 Feb 2023Does molnupiravir improve outcomes in vaccinated COVID-19 patients?
The addition of molnupiravir to usual care does not reduce hospitalization or death in vaccinated, community-dwelling individuals at high risk of serious outcomes of COVID-19, results of the UK-based PANORAMIC trial showed. However, it may provide other benefits such as reducing time to recovery.